CollPlant Biotechnologies... (CLGN)
CollPlant Biotechnologies Statistics
Share Statistics
CollPlant Biotechnologies has 11.45M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 11.45M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | 7.68M |
| Failed to Deliver (FTD) Shares | 7 |
| FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 1.88K, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 1.88K |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.48 and the forward PE ratio is 80.67. CollPlant Biotechnologies's PEG ratio is -0.02.
| PE Ratio | -2.48 |
| Forward PE | 80.67 |
| PS Ratio | 80.07 |
| Forward PS | 0.8 |
| PB Ratio | 3.06 |
| P/FCF Ratio | -2.83 |
| PEG Ratio | -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CollPlant Biotechnologies.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.23.
| Current Ratio | 4.44 |
| Quick Ratio | 4.29 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | -0.19 |
| Debt / FCF | -0.21 |
| Interest Coverage | -1014.76 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $9.04K |
| Profits Per Employee | $-291.39K |
| Employee Count | 57 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 3.69 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -53.64% in the last 52 weeks. The beta is 0.74, so CollPlant Biotechnologies's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -53.64% |
| 50-Day Moving Average | 3.05 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 29.12 |
| Average Volume (20 Days) | 8.02K |
Income Statement
In the last 12 months, CollPlant Biotechnologies had revenue of 515K and earned -16.61M in profits. Earnings per share was -1.45.
| Revenue | 515K |
| Gross Profit | -1.11M |
| Operating Income | -17.25M |
| Net Income | -16.61M |
| EBITDA | -16.21M |
| EBIT | -17.25M |
| Earnings Per Share (EPS) | -1.45 |
Balance Sheet
The company has 11.91M in cash and 3.08M in debt, giving a net cash position of 8.83M.
| Cash & Cash Equivalents | 11.91M |
| Total Debt | 3.08M |
| Net Cash | 8.83M |
| Retained Earnings | -113.35M |
| Total Assets | 18.71M |
| Working Capital | 10.21M |
Cash Flow
In the last 12 months, operating cash flow was -14.09M and capital expenditures -483K, giving a free cash flow of -14.58M.
| Operating Cash Flow | -14.09M |
| Capital Expenditures | -483K |
| Free Cash Flow | -14.58M |
| FCF Per Share | -1.27 |
Margins
Gross margin is -215.53%, with operating and profit margins of -3349.71% and -3225.05%.
| Gross Margin | -215.53% |
| Operating Margin | -3349.71% |
| Pretax Margin | -3225.05% |
| Profit Margin | -3225.05% |
| EBITDA Margin | -3148.16% |
| EBIT Margin | -3349.71% |
| FCF Margin | -2830.29% |
Dividends & Yields
CLGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CLGN is $14, which is 478.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 478.5% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Dec 1, 2016. It was a backward split with a ratio of 2:3.
| Last Split Date | Dec 1, 2016 |
| Split Type | backward |
| Split Ratio | 2:3 |
Scores
| Altman Z-Score | -7.63 |
| Piotroski F-Score | 2 |